UNSPSC 51332402: Prifuroline

This classification denotes an antiarrhythmic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OP2V3XRV2Y. European Medicines Agency schedules Prifuroline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10040MIG. Prifuroline generally arises in the molecular formula C14H16N2O.

UNSPSC 51332402 Prifuroline is a Commodity code for pharmaceutical products, though the recent state and local solicitation tagged under it involves naloxone and drug deactivation systems rather than prifuroline itself. Seminole County, Florida issued an IFB on June 30, 2026 (with a posted response date of July 26, 2023) seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems to support community health initiatives, with quarterly deliveries to the Seminole County Community Health Building. The work reflects a broader state and local pattern of purchasing pharmaceuticals and medical supplies, often for public health programs, emergency response, and harm-reduction initiatives. Issuing bodies under this code include county health departments and public health agencies sourcing medications and medical products to support community programs.

Seminole County, Florida represents the primary recent activity tracked under this code. The Seminole County procurement required competitive sealed bidding through electronic submission, with vendors responsible for all shipping and delivery costs, E-Verify compliance, drug-free workplace certification, and specified insurance coverages including workers' compensation, commercial general liability, and professional liability. The contract carried a two-year initial term with a one-year renewal option and a three-month probationary period, with potential FEMA funding introducing federal environmental compliance requirements. Beyond this single visible opportunity, the code shows limited recent state and local activity in the available dataset.